Alpha2beta1 integrin polymorphism in diffuse astrocytoma patients (2022)
Source: Frontiers in Oncology. Unidades: FCFRP, FM, FMRP
Subjects: MATRIZ EXTRACELULAR, GLIOMA, POLIMORFISMO, ASTROCITOMA
ABNT
TEIXEIRA, Silvia Aparecida et al. Alpha2beta1 integrin polymorphism in diffuse astrocytoma patients. Frontiers in Oncology, v. 12, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.3389/fonc.2022.914156. Acesso em: 23 ago. 2024.APA
Teixeira, S. A., Burim, R. V., Viapiano, M. S., Bidinotto, L. T., Marie, S. K. N., Malheiros, S. M. F., et al. (2022). Alpha2beta1 integrin polymorphism in diffuse astrocytoma patients. Frontiers in Oncology, 12, 1-9. doi:10.3389/fonc.2022.914156NLM
Teixeira SA, Burim RV, Viapiano MS, Bidinotto LT, Marie SKN, Malheiros SMF, Shinjo SMO, Andrade AF, Carlotti Júnior CG. Alpha2beta1 integrin polymorphism in diffuse astrocytoma patients [Internet]. Frontiers in Oncology. 2022 ; 12 1-9.[citado 2024 ago. 23 ] Available from: https://doi.org/10.3389/fonc.2022.914156Vancouver
Teixeira SA, Burim RV, Viapiano MS, Bidinotto LT, Marie SKN, Malheiros SMF, Shinjo SMO, Andrade AF, Carlotti Júnior CG. Alpha2beta1 integrin polymorphism in diffuse astrocytoma patients [Internet]. Frontiers in Oncology. 2022 ; 12 1-9.[citado 2024 ago. 23 ] Available from: https://doi.org/10.3389/fonc.2022.914156